INVO Fertility, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. (Nasdaq: IVF) on June 23, 2026. The filing reports two primary events: the consummation of an acquisition of a joint venture partner and the resolution of a Nasdaq listing compliance issue.
Key Financial Metrics and Transaction Details
The Company's wholly owned subsidiary, INVO Centers, LLC, acquired 100% of the membership interests of HRCFG, LLC, the partner in the Alabama JV (Innovative Fertility Specialists). The total purchase price was $175,001, structured as follows:
- Cash at Closing: $1.00
- Deferred Cash Installments: $48,000 payable pro rata in equal monthly installments over nine months starting October 2026.
- Performance-Based Consideration: $127,000 to be paid from HRCFG's free cash flow.
The filing does not provide specific revenue, profit, cash flow, or margin figures for the Company or the acquired entity. The Alabama JV will be included in the Company's consolidated financial statements on a prospective basis.
Material Changes and Compliance Status
Acquisition Impact: The Company now fully owns the Alabama JV, one of its four existing clinics. The sellers (Hammond, Ray, and Cataldo) will provide transition services for approximately four months and support services for twelve months thereafter.
Nasdaq Compliance Resolution: The Company previously received notices of non-compliance with Nasdaq Listing Rule 5250(c)(1) (Timely Filing Rule) due to late filings of its 2025 Form 10-K and Q1 2026 Form 10-Q. After filing the 10-K on June 2, 2026, and the 10-Q on June 22, 2026, the Nasdaq Listing Qualifications staff notified the Company on June 23, 2026, that it is now in compliance and the matter is closed.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future financial performance, or specific risk factors beyond the disclosed transaction terms. The primary contingency noted is the payment of $127,000 contingent upon the generation of free cash flow by the acquired entity.
Key Facts for Investor Verification
- Verify the total consideration of $175,001 and the specific payment schedule (cash vs. free cash flow contingent).
- Confirm the prospective consolidation date for the Alabama JV in upcoming financial reports.
- Review the recently filed Form 10-K (filed June 2, 2026) and Form 10-Q (filed June 22, 2026) for detailed financial performance data not included in this 8-K.
- Monitor the Company's ongoing compliance with Nasdaq listing standards following the resolution of the timely filing issue.